EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders

Peter D Szigetvari, Sudarshan Patil, Even Birkeland, Rune Kleppe, Jan Haavik

Neurochemistry International · 2023

DOI: 10.1016/j.neuint.2023.105629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2023. Verfasst von Peter D Szigetvari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University of Bergen, 5009, Bergen, Norway. Electronic address: Peter.Szigetvari@uib.no. Hauptthemen laut MEDLINE: Tyrosinemias, Phenylketonurias, Neurodevelopmental Disorders. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest Regionalt Helseføretak, Stiftelsen Kristian Gerhard Jebsen, Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylketonuria (PKU) is an autosomal recessive metabolic disorder caused by mutations in the phenylalanine hydroxylase (PAH) gene, resulting in phenylalanine accumulation and impaired tyrosine production. In Tyrosinemia type 1 (TYRSN1) mutations affect fumarylacetoacetate hydrolase, leading to accumulation of toxic intermediates of tyrosine catabolism. Treatment of TYRSN1 with nitisinone results in extreme tissue levels of tyrosine. Although PKU and TYRSN1 have opposite effects on tyrosine levels, both conditions have been associated with neuro-psychiatric symptoms typically present in ADHD, possibly indicating an impaired dopamine (DA) synthesis. However, concrete in vivo data on the possible molecular basis for disrupted DA production under disease mimicking conditions have been lacking. In pursuit to uncover associated molecular mechanisms, we exposed an established, DA producing cell line (PC12) to different concentrations of phenylalanine and tyrosine in culture media. We measured the effects on viability, proteomic composition, tyrosine, DA and tyrosine hydroxylase (TH) levels and TH phosphorylation. TH catalyzes the rate-limiting step in DA synthesis. High extracellular levels of phenylalanine depleted cells of intracellular tyrosine and DA. Compared to physiological levels (75 μM), either low (35 μM) or high concentrations of tyrosine (275 or 835 μM) decreased cellular DA, TH protein, and its phosphorylation levels. Using deep proteomic analysis, we identified multiple proteins, biological processes and pathways that were altered, including enzymes and transporters involved in amino acid metabolism. Using this information and published data, we developed a mathematical model to predict how extracellular levels of aromatic amino acids can affect the cellular synthesis of DA via different mechanisms. Together, these data provide new information about the normal regulation of neurotransmitter synthesis and how this may be altered in neurometabolic disorders, such as PKU and TYRSN1, with implications for the treatment of cognitive symptoms resulting from comorbid neurodevelopmental disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TyrosinemiasPhenylketonuriasNeurodevelopmental DisordersRatsAnimalsDopamineTyrosinePhenylalaninePC12 CellsProteomicsTyrosine 3-Monooxygenase

Stichwörter der Autor:innen

Attention deficit hyperactivity disorder (ADHD)Dopamine (DA) biosynthesisHuman hereditary tyrosinemia type 1 (TYRSN1)Precursor couplingProteomicsTyrosine hydroxylase (TH)

Substanzen

DopamineTyrosinePhenylalanineTyrosine 3-Monooxygenase

Autor:innen und Institutionen

  • Department of Biomedicine, University of Bergen, 5009, Bergen, Norway. Electronic address: Peter.Szigetvari@uib.no.
  • Department of Biomedicine, University of Bergen, 5009, Bergen, Norway. Electronic address: Sudarshan.Patil@uib.no.
  • Department of Genetic Research & Bioinformatics, Norwegian Institute of Public Health, Bergen, Norway; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway.
  • Norwegian Centre for Maritime- and Diving Medicine, Department of Occupational Medicine, Haukeland University Hospital, 5021, Bergen, Norway. Electronic address: Rune.Kleppe@helse-bergen.no.
  • Department of Biomedicine, University of Bergen, 5009, Bergen, Norway; Bergen Center of Brain Plasticity, Division of Psychiatry, Haukeland University Hospital, Norway. Electronic address: Jan.Haavik@uib.no.

Förderung

  • Helse Vest Regionalt Helseføretak
  • Stiftelsen Kristian Gerhard Jebsen
  • Norges Forskningsråd
  • Horizon 2020
  • Horizon 2020 European Innovation Council Fast Track to Innovation
  • Chiropractic and Osteopathic College of Australasia

Zitieren

APA

Szigetvari, P. D., Patil, S., Birkeland, E., Kleppe, R., & Haavik, J. (2023). The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders. Neurochemistry International. https://doi.org/10.1016/j.neuint.2023.105629

Vancouver

Szigetvari PD, Patil S, Birkeland E, Kleppe R, Haavik J. The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders. Neurochemistry International. 2023. doi:10.1016/j.neuint.2023.105629

BibTeX
@article{Szigetvari2023,
  author = {Szigetvari, Peter D and Patil, Sudarshan and Birkeland, Even and Kleppe, Rune and Haavik, Jan},
  title = {The effects of phenylalanine and tyrosine levels on dopamine production in rat PC12 cells. Implications for treatment of phenylketonuria, tyrosinemia type 1 and comorbid neurodevelopmental disorders},
  journal = {Neurochemistry International},
  year = {2023},
  doi = {10.1016/j.neuint.2023.105629}
}
Kostenlos starten →